Global EditionASIA 中文双语Français
World
Home / World / China-Africa

Senegal receives first batch of Chinese COVID-19 vaccine

Xinhua | Updated: 2021-02-18 14:08
Share
Share - WeChat
Senegal's President Macky Sall speaks after cargo containing China's Sinopharm coronavirus disease (COVID-19) vaccine is unloaded from a plane in Diass, Senegal, Feb 17, 2021. [Photo/Xinhua]

DAKAR - Senegal on Wednesday night received the first batch of China's Sinopharm COVID-19 vaccine.

Senegalese President Macky Sall, First Lady Marieme Faye Sall, senior government officials, Chinese Ambassador to Senegal Xiao Han and representatives of the World Health Organization also attended the delivery ceremony at Blaise Diagne International Airport.

The first batch of 200,000 doses of vaccine were conveyed by a special flight of the national company Air Senegal from Beijing.

Speaking at the ceremony, President Sall first expressed his "sincere thanks" to his Chinese counterpart Xi Jinping for the acquisition of these doses of vaccine.

He also thanked Ambassador Xiao for the follow-up of "this complex operation".

Apart from these 200,000 doses of Sinopharm vaccine, Sall said that his country has started the process of acquiring other vaccines, and will receive 6.798 million doses in the coming weeks for mass vaccination.

The country plans to vaccinate 20 percent of its population, which is about 3.5 million people, in the first phase of mass vaccination.

Senegal has so far reported 31,771 COVID-19 cases with 26,095 recoveries and 769 deaths.

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US